HeartEase App Development Update FAQ

What is HeartEase?

HeartEase is an AI-powered app designed to provide cardiovascular and emotional health insights through intelligent monitoring, real-time feedback, and personalized wellness recommendations.

Who is developing HeartEase?

NeuralBase AI Ltd., operating under its enterprise brand BMP AI, is developing HeartEase.

What platforms will HeartEase be available on?

HeartEase will be available on Android and iOS platforms, with the Android version currently undergoing final testing and the iOS version scheduled to enter testing soon.

When is HeartEase expected to be released?

The public release of the Android app is expected in the coming weeks, with the iOS version to follow after testing. The closing of the HeartEase transaction is expected by no later than September 15, 2025.

What are the benefits of HeartEase?

HeartEase leverages AI to offer adaptive user experiences for proactive wellness management, including personalized health insights and recommendations based on behavioral and biometric data analysis.

How does HeartEase work?

HeartEase uses NeuralBase AI’s proprietary AI platform to analyze behavioral insights and biometric data, providing real-time feedback and personalized wellness recommendations to users.

What are the next steps for HeartEase?

The next steps include final testing for the Android version, followed by iOS testing, to ensure feature parity and performance consistency across platforms before public release.

Where can I find more information about NeuralBase AI Ltd.?

Additional information about NeuralBase AI Ltd. is available at https://www.neuralbase.ai or by visiting https://www.sec.gov.

What are the implications of HeartEase’s launch?

The launch of HeartEase will validate the platform’s technology in real-world conditions, provide user feedback for enhancements, support strategic partnerships, and scale NeuralBase AI’s digital health ecosystem.